以上都是叮当快药"骑手双向守护"计划的真实缩影。 今年7月，叮当快药正式启动覆盖北京、上海、广州等10座城市的"骑手双向守护计划"，在全国数百家 叮当智慧药房设立健康小屋，为户外工作者提供六大爱心服务，包括免费防暑药品、应急外伤处理、24 小时冷热饮用水供应、临时避暑休息区、血压/体温检测及线上药师防暑咨询，已惠及数千名配送员。 "全国的快递员、配送员数以千万计，他们就像城市的毛细血管一样，为城市的发展源源不断地输送养 分。他们的辛劳和努力应当被看见，他们的健康和安全也需要被守护" 。叮当快药相关负责人表 示。"考虑到近期国内出现基孔肯雅热感染，骑手们早出晚归、风餐露宿，是蚊虫叮咬的高风险群体， 我们专门在爱心包里加入了驱蚊产品，希望帮助骑手们做好防蚊工作，守护大家健康"。 自入伏以来，全国多地遭遇持续高温与强降雨交替的特殊天气。为了保障城市运转，外卖骑手、快递员 等户外工作者仍坚守岗位，为市民生活带来便利。 7月下旬，叮当快药"骑手双向守护"项目组深入北京市东城区多个快递站点，开展爱心物资捐赠活动。 现场，项目组为快递小哥们送上精心准备的藿香正气水、冰感喷雾、创可贴等实用防暑物资，切实解决 户外工作者在高温 ...

Core Insights - Dingdang Health is intensifying its efforts in the pharmaceutical new retail sector by launching a 15-minute urgent medication delivery service and signing agreements with multiple pharmaceutical companies to advance the "Original Drug Supply Alliance" project [1][2] Group 1: Company Developments - Dingdang Kuaiyao has achieved a cumulative delivery of 123 million orders at night over the past ten years, evolving from a single medication retail platform to a comprehensive health management platform that includes online health consultations, medication guidance, and post-diagnosis health management [2] - The company has introduced a multi-functional smart solution called the A-LL dual-wheel drive growth model, focusing on enhancing brand influence for pharmaceutical companies and expanding its pharmacy network in key regions such as Beijing, Tianjin, Shanghai, Hangzhou, Guangzhou, and Shenzhen [2] Group 2: Market Trends - The demand for immediate medication retail is increasing due to changing consumer habits and a heightened focus on health consumption, particularly among severe patients, children, and the elderly, who view original drugs as essential for quality living [1] - The deepening impact of centralized procurement policies has led to some original drugs exiting hospital channels, prompting patients to turn to online pharmaceutical platforms for their needs [1] Group 3: Policy Support - Continuous policy support is a significant backdrop for Dingdang Health's push into pharmaceutical new retail, with the Ministry of Commerce and the National Health Commission promoting health consumption and the integration of medical services into retail pharmacy operations [3] - The 2025 action plan emphasizes the role of retail pharmacies in health promotion and encourages the adoption of innovative "Internet+" medical service models, enhancing the flow of electronic prescriptions and improving convenient medical service demands [3]

Core Insights - The article highlights the significant increase in demand for allergy medications in Beijing, particularly during the pollen allergy season, with a search volume increase of 83.35% and a sales volume increase of 80.27% for related medications [1][3]. Group 1: Company Initiatives - Dingtang Health, through its platform Dingtang Fast Medicine, has launched an "Allergy Index" tool that includes features such as allergy levels, an "allergy map," and self-assessment tools to educate users about allergies and help them manage their symptoms [1]. - The company has introduced an "Allergy Medication Zone" to facilitate quick access to allergy medications, along with professional consultation services from pharmacists and doctors [1]. Group 2: Market Demand and User Behavior - There is a notable demand for nighttime allergy medications, with nasal allergy medication orders being 1.8 times higher than those for eye allergy medications, indicating a specific need among users [3]. - The delivery service operates 24/7, providing timely access to medications for allergy sufferers, particularly during peak allergy seasons [3].

上市三年不盈利的叮当健康，又添了商誉减值新问题 上市近三年时间，叮当健康持续亏损。近日，叮当健康发布2024年度业绩报告。报告显示，2024年叮当 健康全年营收46.69亿元，同比减少3.87%；股东应占亏损3.76亿元，同比扩大66.73%。经历2022年股东应占亏 损28.33亿元的断崖式下滑，2023年叮当健康股东应占亏损有所收窄，但仍亏损2.26亿元，2024年叮当健康的 亏损趋势并未得到扭转。对于期内亏损增加，叮当健康方面表示，主要原因为考虑到公司若干子公司业绩表 现上的挑战，公司于2024财年计提分摊于相关子公司的商誉确认减值亏损约1.99亿元及其他无形资产确认减值 亏损680万元。 三年亏损近34.35亿元 叮当健康2024年实现总收入46.69亿元，同比减少3.9%。从增长趋势来看，自2021年之后，叮当健康的营 收增速便呈现下滑态势，到2024年甚至出现了负增长。 对于总收入减少，叮当健康方面表示，由于整体市场需求放缓，以及部分区域竞争加剧。在此情况下， 公司主动调整与优化部分非核心城市，暂停了包括重庆、南京、济南、福州等城市的智慧药房连锁经营，将 资源聚焦深耕优势区域，包括北京、上海、深圳 ...